Did you know?
ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.
Free Newsletter
Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!
Free Report
For better result, minimum character length is four(4)
China is close to finalizing a draft proposal of a...
In the second half of 2009, Sinovac Biotech was reporting...
Tongjitang Chinese Medicines Co. is still considering the...
Sinovac Biotech lowered its financial guidance for 2010...
Sanofi-Aventis will acquire BMP Sunstone for $520...
Sinovac Biotech was granted SFDA approval to begin...
Kangmei Pharma will raise up to $529 million through a...
Sinovac Biotech submitted a request to the SFDA to...
In 2010, life science VC investing in China climbed an...
Sinovac Biotech has filed an application with the SFDA...
ChinaBio® News
Greg Scott Interviewed at BIO-Europe Spring
How to bring your China assets to China in 8 minutes
"Mr. Bio in China."
Mendelspod Interview
Multinational pharma held to a higher standard in China
